Moller HJ - Search Results

1

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.

Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S. Vajavaara H, et al. Among authors: moller hj. Haematologica. 2021 Sep 1;106(9):2502-2506. doi: 10.3324/haematol.2020.278182. Haematologica. 2021. PMID: 33764002 Free PMC article. No abstract available.

2

Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.

Møller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, Attermann J, Nexø E, Kronborg G. Møller HJ, et al. Crit Care Med. 2006 Oct;34(10):2561-6. doi: 10.1097/01.CCM.0000239120.32490.AB. Crit Care Med. 2006. PMID: 16915112

3

Soluble CD163 levels in children with sickle cell disease.

Moller HJ, Nielsen MJ, Bartram J, Dick MC, Height SE, Moestrup SK, Rees DC. Moller HJ, et al. Br J Haematol. 2011 Apr;153(1):105-10. doi: 10.1111/j.1365-2141.2011.08580.x. Epub 2011 Feb 20. Br J Haematol. 2011. PMID: 21332709 Free article.

4

Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.

Greisen SR, Moller HJ, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Jørgensen A, Hvid M, Deleuran B. Greisen SR, et al. Among authors: moller hj. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):689-92. Epub 2011 Sep 1. Clin Exp Rheumatol. 2011. PMID: 21813065 Clinical Trial.

5

Soluble CD163.

Møller HJ. Møller HJ. Scand J Clin Lab Invest. 2012 Feb;72(1):1-13. doi: 10.3109/00365513.2011.626868. Epub 2011 Nov 7. Scand J Clin Lab Invest. 2012. PMID: 22060747 Review.

6

Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.

Grønbaek H, Sandahl TD, Mortensen C, Vilstrup H, Møller HJ, Møller S. Grønbaek H, et al. Among authors: moller s, moller hj. Aliment Pharmacol Ther. 2012 Jul;36(2):173-80. doi: 10.1111/j.1365-2036.2012.05134.x. Epub 2012 May 16. Aliment Pharmacol Ther. 2012. PMID: 22591184 Free article.

7

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF. Andersen MN, et al. Among authors: moller hj. Eur J Haematol. 2014 Jul;93(1):41-7. doi: 10.1111/ejh.12296. Epub 2014 Mar 20. Eur J Haematol. 2014. PMID: 24612259

8

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H. Kazankov K, et al. Among authors: moller hj. Hepatology. 2014 Aug;60(2):521-30. doi: 10.1002/hep.27129. Epub 2014 May 6. Hepatology. 2014. PMID: 24623375

9

Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.

Stilund M, Reuschlein AK, Christensen T, Møller HJ, Rasmussen PV, Petersen T. Stilund M, et al. Among authors: moller hj. PLoS One. 2014 Jun 2;9(6):e98588. doi: 10.1371/journal.pone.0098588. eCollection 2014. PLoS One. 2014. PMID: 24886843 Free PMC article.

10

Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.

Kallestrup M, Møller HJ, Tankisi H, Andersen H. Kallestrup M, et al. Among authors: moller hj. Diabet Med. 2015 Jan;32(1):54-61. doi: 10.1111/dme.12568. Epub 2014 Sep 18. Diabet Med. 2015. PMID: 25156085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,326 results

Search Page